179 related articles for article (PubMed ID: 22985345)
1. Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines.
El Ridi R; Tallima H
J Parasitol; 2013 Apr; 99(2):194-202. PubMed ID: 22985345
[TBL] [Abstract][Full Text] [Related]
2. Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory--secretory candidate vaccine antigens.
El Ridi R; Tallima H; Mahana N; Dalton JP
Microbes Infect; 2010 Sep; 12(10):700-9. PubMed ID: 20452455
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant selection for vaccination against murine schistosomiasis.
El Ridi R; Tallima H
Scand J Immunol; 2012 Dec; 76(6):552-8. PubMed ID: 22882457
[TBL] [Abstract][Full Text] [Related]
4. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
5. Papain-Based Vaccination Modulates Schistosoma mansoni Infection-Induced Cytokine Signals.
Abdel Aziz N; Tallima H; Hafez EA; El Ridi R
Scand J Immunol; 2016 Feb; 83(2):128-38. PubMed ID: 26603950
[TBL] [Abstract][Full Text] [Related]
6. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant.
Mountford AP; Anderson S; Wilson RA
J Immunol; 1996 Jun; 156(12):4739-45. PubMed ID: 8648120
[TBL] [Abstract][Full Text] [Related]
7. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
Tallima H; Tadros MM; El Ridi R
Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
[TBL] [Abstract][Full Text] [Related]
8. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase.
Tallima H; Dvořák J; Kareem S; Abou El Dahab M; Abdel Aziz N; Dalton JP; El Ridi R
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005443. PubMed ID: 28346516
[TBL] [Abstract][Full Text] [Related]
9. Schistosoma mansoni: protective immunity in IL-4-deficient mice.
King CL; Malhotra I; Jia X
Exp Parasitol; 1996 Nov; 84(2):245-52. PubMed ID: 8932774
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni.
Wynn TA; Oswald IP; Eltoum IA; Caspar P; Lowenstein CJ; Lewis FA; James SL; Sher A
J Immunol; 1994 Dec; 153(11):5200-9. PubMed ID: 7525727
[TBL] [Abstract][Full Text] [Related]
11. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
Hoffmann KF; James SL; Cheever AW; Wynn TA
J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689
[TBL] [Abstract][Full Text] [Related]
12. Identification of Schistosoma mansoni antigens recognized by T cells of C57BL/6 mice immunized with gamma-irradiated cercariae.
Osman A; el Ridi R; Guirguis N; Dean DA
J Parasitol; 1994 Jun; 80(3):421-31. PubMed ID: 8195944
[TBL] [Abstract][Full Text] [Related]
13. Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity.
El Ridi R; Tallima H; Selim S; Donnelly S; Cotton S; Gonzales Santana B; Dalton JP
PLoS One; 2014; 9(1):e85401. PubMed ID: 24465551
[TBL] [Abstract][Full Text] [Related]
14. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection.
Pemberton RM; Wilson RA
Immunology; 1995 Feb; 84(2):310-6. PubMed ID: 7751008
[TBL] [Abstract][Full Text] [Related]
15. Impact of interleukin-1 and interleukin-6 in murine primary schistosomiasis.
El Ridi R; Wagih A; Salem R; Mahana N; El Demellawy M; Tallima H
Int Immunopharmacol; 2006 Jul; 6(7):1100-8. PubMed ID: 16714213
[TBL] [Abstract][Full Text] [Related]
16. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite.
Wynn TA; Reynolds A; James S; Cheever AW; Caspar P; Hieny S; Jankovic D; Strand M; Sher A
J Immunol; 1996 Nov; 157(9):4068-78. PubMed ID: 8892641
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
Ricciardi A; Dalton JP; Ndao M
Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
[TBL] [Abstract][Full Text] [Related]
18. Application of adult worm and lung-stage antigens to immunize against Schistosoma mansoni using cytokines as adjuvants.
Afifi MA; El-Wakil HS; Abdel-Ghaffar MM; Mohamed RT
J Egypt Soc Parasitol; 2006 Apr; 36(1):351-62, 2p following 362. PubMed ID: 16605124
[TBL] [Abstract][Full Text] [Related]
19. Induction of Protective Immune Responses Against Schistosomiasis haematobium in Hamsters and Mice Using Cysteine Peptidase-Based Vaccine.
Tallima H; Dalton JP; El Ridi R
Front Immunol; 2015; 6():130. PubMed ID: 25852696
[TBL] [Abstract][Full Text] [Related]
20. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
Fonseca CT; Pacífico LG; Barsante MM; Rassi T; Cassali GD; Oliveira SC
Microbes Infect; 2006 Aug; 8(9-10):2509-16. PubMed ID: 16914349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
